A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder
Bibliographic Data
| ID | 15529779 |
|---|---|
| Authors | Timothy D Becker (0000-0002-8400-1312, New York Hospital Queens, corresponding author), Evan L Eschliman (0000-0001-6478-4615, Johns Hopkins University), Ashish P Thakrar (0000-0002-4406-6752, University of Pennsylvania), Lawrence Hsin Yang (0000-0001-7779-7423, New York University) |
| Year | 2023 |
| Volume | 14 |
| Pages | 1184951-1184951 |
| Publication date | 2023-09-27 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1184951 |
| PMID | 37829763 |
| OpenAlex | W4387117440 |
| Language | EN |
| Citations received | 2 |
| References cited | 86 |
Stigma toward people taking medication for opioid use disorder (MOUD) is prevalent, harmful to the health and well-being of this population, and impedes MOUD treatment resource provision, help-seeking, and engagement in care. In recent years, clinicians have implemented new models of MOUD-based treatment in parts of the United States that integrate buprenorphine initiation into emergency departments and other acute general medical settings, with post-discharge linkage to office-based treatment. These service models increase access to MOUD and they have potential to mitigate stigma toward opioid use and MOUD. However, the empirical literature connecting these emerging service delivery models to stigma outcomes remains underdeveloped. This paper aims to bridge the stigma and health service literatures via a conceptual model delineating how elements of emerging MOUD service models can reduce stigma and increase behavior in pursuit of life goals. Specifically, we outline how new approaches to three key processes can counter structural, public, and self-stigma for this population: (1) community outreach with peer-to-peer influence, (2) clinical evaluation and induction of MOUD in acute care settings, and (3) transition to outpatient maintenance care and early recovery. Emerging service models that target these three processes can, in turn, foster patient empowerment and pursuit of life goals. There is great potential to increase the well-being of people who use opioids by reducing stigma against MOUD via these structural changes
Buprenorphine · Environmental health · Opioid · Opioid use disorder · Outreach · Political science · Population · Psychiatry · Stigma (botany · Medicine · Mental Health Treatment and Access · Nursing · Opioid Use Disorder Treatment · Psychology · Substance Abuse Treatment and Outcomes
Mortality risk during and after opioid substitution treatment
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Stigma, Discrimination, Treatment Effectiveness, and Policy
Stigma and substance use disorders
Self‐stigma and the “why try” effect
Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery
Barriers to Medications for Addiction Treatment
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Public support for safe consumption sites and syringe services programs to combat the opioid epidemic
Structural stigma
The association between perceived stigma and substance use disorder treatment outcomes
Social Stigma Toward Persons With Prescription Opioid Use Disorder
The effects of peer support on empowerment, self-efficacy, and internalized stigma
Conceptualizing and measuring mental illness stigma
You're Nothing But a Junkie”
Reducing Stigma
Ambiguous identities of drugs and people
Like being put on an ice floe and shoved away”
A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices
Stigma as a public health tool
Stigma and substance use disorders
Stigma as a Fundamental Cause of Population Health Inequalities
Understanding and Addressing Aids-Related Stigma
How Massachusetts, Vermont, and New York Are Taking Action to Address the Opioid Epidemic
Culture and stigma
Portraying mental illness and drug addiction as treatable health conditions
Methadone as Social Control
Intervening within and across levels
The social course of epilepsy
Intervention stigma
Conceptualizing Stigma
| Unique citing works | 2 |
|---|---|
| Citations per year | 1 |
| Citation span | 2024 - 2026 (3) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |